产品中心 抗体 其他一抗

所有图片(1/2)

Phospho-Myosin Light Chain 2 (Ser19) Recombinant Rabbit mAb (S-3335-18)

Myosin regulatory light polypeptide 9,Myosin regulatory light chain 2,smooth muscle isoform,Myosin regulatory light chain 9,Myl9,Myrl2

价格 600.00 供应商现货 : 3-5个工作日
货号 S0B6797
规格
数量
收藏 分享

产品介绍 评论(0)

产品规格
  • 宿主来源

    Rabbit
  • 抗原名称

    Phospho-Myosin Light Chain 2 (Ser19)
  • 分子别名

    Myosin regulatory light polypeptide 9, Myosin regulatory light chain 2, smooth muscle isoform, Myosin regulatory light chain 9, Myl9, Myrl2
  • 免疫原

    Synthetic Peptide
  • 细胞定位

    Cytoplasm, Cytoskeleton
  • Accession

    Q9CQ19
  • 克隆号

    S-3335-18
  • 抗体类型

    Recombinant mAb
  • 抗体同种型

    IgG
  • 反应种属 ?

    Ms
  • 阳性样本

    C2C12, C2C12 (treated with 50 µM ML-7 for 15 minutes)
  • 纯化方式

    Protein A
  • 浓度

    0.5 mg/ml
  • 标记

    Unconjugated
  • 性状

    Liquid
  • 缓冲体系

    PBS, 40% Glycerol, 0.05% BSA, 0.03% Proclin 300

  • 储存条件

    12 months from date of receipt / reconstitution, -20 °C as supplied

  • 应用

    WB

  • 稀释度

    应用 稀释度 推荐种属
    Dot Blot 1:1000
    WB 1:1000-1:2000 Ms
背景介绍
  • Phospho-Myosin Light Chain 2 (Ser19) refers to the specific post-translational modification of the regulatory myosin light chain (MLC2, also known as MLC20 in smooth muscle or MLC2a/2b in striated muscle) where a phosphate group is added to the serine residue at position 19. This phosphorylation event is primarily catalyzed by Myosin Light Chain Kinase (MLCK) in response to increased intracellular calcium levels, although Rho-associated kinase (ROCK) can also contribute, particularly in smooth muscle tone regulation. The addition of the phosphate group at Ser19 induces a conformational change in the myosin head, enabling it to interact with actin filaments and initiate ATP-dependent cross-bridge cycling, which is the fundamental mechanism driving muscle contraction and non-muscle cell motility, such as cytokinesis and cell migration. Consequently, detection of Phospho-MLC2 (Ser19) is widely used as a key biomarker for assessing cellular contractility and cytoskeletal dynamics in various physiological and pathological contexts.

  • 免疫印迹

    • WB result of Phospho-Myosin Light Chain 2 (Ser19) Recombinant Rabbit mAb
      Blocking/Diluting buffer and concentration: 5% NFDM/TBST
      Primary antibody: Phospho-Myosin Light Chain 2 (Ser19) Recombinant Rabbit mAb at 1/1000 dilution
      Lane 1: untreated C2C12 whole cell lysate 20 µg
      Lane 2: C2C12 treated with 50 µM ML-7 for 15 minutes whole cell lysate 20 µg
      Lane 3: C2C12 whole cell lysate 20 µg
      Secondary antibody: Goat Anti- rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
      Predicted MW: 20 kDa
      Observed MW: 22 kDa

  • 斑点杂交

    • Dot blot result of Phospho-Myosin Light Chain 2 (Ser19) Recombinant Rabbit mAb
      Lane 1: Myosin Light Chain 2 (Ser19) phospho peptide
      Lane 2: Myosin Light Chain 2 phospho peptide
      Lane 3: Myosin Light Chain 2 (Ser19) unmodified peptide
      Primary antibody: Phospho-Myosin Light Chain 2 (Ser19) Recombinant Rabbit mAb at 1/1000 dilution
      Secondary antibody: Goat Anti-rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution

评论(0)